Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with <i>RAS</i>/<i>BRAF</i> Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II TrialHuabin Hu, Yanhong Deng, Kun Wang et al.|The Oncologist|2020Cited by 50
What Works for Controlling Meningitis Outbreaks: A Case Study from ChinaXiyu Zhang, Fuqiang Cui, Zhongju Li et al.|Vaccines|2023Cited by 1